Oral delivery strategies for nutraceuticals: Delivery vehicles and absorption enhancers

Trends in Food Science and Technology

Volumn 53, Issue , 2016, Pages 90-101

  Gleeson, John P ^a   Ryan, Sinéad M ^a   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Food derived bioactives; Intestinal permeation enhancers; Nanoparticles; Nutraceuticals; Oral bioavailability; Oral delivery

Indexed keywords

BIOCHEMISTRY; FATTY ACIDS; MOLECULES; NANOPARTICLES; PEPTIDES; SOLUBILITY;

BIOACTIVES; INTESTINAL PERMEATIONS; NUTRACEUTICALS; ORAL BIOAVAILABILITIES; ORAL DELIVERY;

DRUG PRODUCTS;

EID: 84969847933     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.05.007     Document Type: Review

References (110)

1. Aarak K.E., Kirkhus B., Holm H., Vogt G., Jacobsen M., Vegarud G.E. Release of EPA and DHA from salmon oil - a comparison of in vitro digestion with human and porcine gastrointestinal enzymes. British Journal of Nutrition 2013, 110:1402-1410.
2. Adarme-Vega T.C., Thomas-Hall S.R., Schenk P.M. Towards sustainable sources for omega-3 fatty acids production. Current Opinion in Biotechnology 2014, 26:14-18.
3. Aditya N.P., Shim M., Lee I., Lee Y., Im M.H., Ko S. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. Journal of Agricultural and Food Chemistry 2013, 61:1878-1883.
4. Aguirre T.A.S., Rosa M., Guterres S.S., Pohlmann A.R., Coulter I., Brayden D.J. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models. European Journal of Pharmaceutics and Biopharmaceutics 2014, 88:856-865.
5. Akanbi T.O., Sinclair A.J., Barrow C.J. Pancreatic lipase selectively hydrolyses DPA over EPA and DHA due to location of double bonds in the fatty acid rather than regioselectivity. Food Chemistry 2014, 160:61-66.
6. Arab-Tehrany E., Jacquot M., Gaiani C., Imran M., Desobry S., Linder M. Beneficial effects and oxidative stability of omega-3 long-chain polyunsaturated acids. Trends in Food Science & Technology 2012, 25:24-33.
7. Arroyo-Maya I.J., McClements D.J. Biopolymer nanoparticles as potential delivery systems for anthocyanins: fabrication and properties. Food Research International 2015, 69:1-8.
8. Barve A., Chen C., Hebbar V., Desiderio J., Saw C.L., Kong A.N. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharmaceutics and Drug Disposition 2009, 30:356-365.
9. Belhaj N., Dupuis F., Arab-Tehrany E., Denis F.M., Paris C., Lartaud I., et al. Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA's nanoemulsions. European Journal of Pharmaceutical Sciences 2012, 47:305-312.
10. Braeckman R.A., Stirtan W.G., Soni P.N. Effects of icosapent ethyl (eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects. Clinical Pharmacology in Drug Development 2015, 4:143-148.
11. Braithwaite M.C., Tyagi C., Tomar L.K., Kumar P., Choonara Y.E., Pillay V. Nutraceutical-based therapeutics and formulation strategies augmenting their efficiency to complement modern medicine: an overview. Journal of Functional Foods 2014, 6:82-99.
12. Brayden D.J., Gleeson J.P., Walsh E.G. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in caco-2 cells. European Journal of Pharmaceutics and Biopharmaceutics 2014, 88:830-839.
13. Brayden D.J., Walsh E. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative. The AAPS Journal 2014, 16:1064-1076.
14. Brown E.S., Allsopp P.J., Magee P.J., Gill C.I., Nitecki S., Strain C.R., et al. Seaweed and human health. Nutrition Reviews 2014, 72:205-216.
15. Buckley S.T., Frank K.J., Fricker G., Brandl M. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations". European Journal of Pharmaceutical Sciences 2013, 50:8-16.
16. Cai H., Scott E., Kholghi A., Andreadi C., Rufini A., Karmokar A., et al. Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Science Translational Medicine 2015, 7. 298ra117.
17. Chassaing B., Koren O., Goodrich J.K., Poole A.C., Srinivasan S., Ley R.E., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015, 519:92-96.
18. Chatterton D.E., Nguyen D.N., Bering S.B., Sangild P.T. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. The International Journal of Biochemistry and Cell Biology 2013, 45:1730-1747.
19. Chen J., Liu S., Ye R., Cai G., Ji B., Wu Y. Angiotensin-I converting enzyme (ACE) inhibitory tripeptides from rice protein hydrolysate: purification and characterization. Journal of Functional Foods 2013, 5:1684-1692.
20. Choonara B.F., Choonara Y.E., Kumar P., Bijukumar D., du Toit L.C., Pillay V. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnology Advances 2014, 32:1269-1282.
21. Déat-Lainé E., Hoffart V., Garrait G., Jarrige J.-F., Cardot J.-M., Subirade M., et al. Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery. Pharmaceutical Research 2013, 30:721-734.
22. Deckelbaum R.J., Torrejon C. The Omega-3 fatty acid nutritional landscape: health benefits and sources. Journal of Nutrition 2012, 142:587S-591S.
23. Dhule S.S., Penfornis P., Frazier T., Walker R., Feldman J., Tan G., et al. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine: Nanotechnology, Biology and Medicine 2012, 8:440-451.
24. Dias D.A., Urban S., Roessner U. A historical overview of natural products in drug discovery. Metabolites 2012, 2:303-336.
25. Duan X., Wu F., Li M., Yang N., Wu C., Jin Y., et al. Naturally occurring angiotensin I-converting enzyme inhibitory peptide from a fertilized egg and its inhibitory mechanism. Journal of Agricultural and Food Chemistry 2014, 62:5500-5506.
26. Dwivedi P., Khatik R., Khandelwal K., Taneja I., Raju K.S.R., Wahajuddin, et al. Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats. International Journal of Pharmaceutics 2014, 466:321-327.
27. Ensign L.M., Henning A., Schneider C.S., Maisel K., Wang Y.Y., Porosoff M.D., et al. Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Molecular Pharmaceutics 2013, 10:2176-2182.
28. Gao X., He C., Xiao C., Zhuang X., Chen X. Biodegradable pH-responsive polyacrylic acid derivative hydrogels with tunable swelling behavior for oral delivery of insulin. Polymer 2013, 54:1786-1793.
29. Girgih A.T., Myrie S.B., Aluko R.E., Jones P.J.H. Is category 'A' status assigned to soy protein and coronary heart disease risk reduction health claim by the United States Food and Drug Administration still justifiable?. Trends in Food Science & Technology 2013, 30:121-132.
30. Gleeson J.P., Heade J., Ryan S.M., Brayden D.J. Stability, toxicity and intestinal permeation enhancement of two food-derived antihypertensive tripeptides, Ile-Pro-Pro and Leu-Lys-Pro. Peptides 2015, 71:1-7.
31. Gonzalez-Castejon M., Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obesity: a review. Pharmacological Research 2011, 64:438-455.
32. Gulotta A., Saberi A.H., Nicoli M.C., McClements D.J. Nanoemulsion-based delivery systems for polyunsaturated (omega-3) oils: formation using a spontaneous emulsification method. Journal of Agricultural and Food Chemistry 2014, 62:1720-1725.
33. Guri A., Gulseren I., Corredig M. Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells. Food and Function 2013, 4:1410-1419.
34. Helgason T., Awad T.S., Kristbergsson K., Decker E.A., McClements D.J., Weiss J. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles. Journal of Agricultural and Food Chemistry 2009, 57:8033-8040.
35. Hosseini S.M.H., Emam-Djomeh Z., Sabatino P., Van der Meeren P. Nanocomplexes arising from protein-polysaccharide electrostatic interaction as a promising carrier for nutraceutical compounds. Food Hydrocolloids 2015, 50:16-26.
36. Huttunen K.M., Raunio H., Rautio J. Prodrugs-from serendipity to rational design. Pharmacological Reviews 2011, 63:750-771.
37. Hu B., Xie M., Zhang C., Zeng X. Genipin-structured peptide-polysaccharide nanoparticles with significantly improved resistance to harsh gastrointestinal environments and their potential for oral delivery of polyphenols. Journal of Agricultural and Food Chemistry 2014, 62:12443-12452.
38. Kakkar V., Singh S., Singla D., Kaur I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Molecular Nutrition and Food Research 2011, 55:495-503.
39. Karsdal M.A., Riis B.J., Mehta N., Stern W., Arbit E., Christiansen C., et al. Lessons learned from the clinical development of oral peptides. British Journal of Clinical Pharmacology 2015, 79:720-732.
40. Karthikeyan S., Rajendra Prasad N., Ganamani A., Balamurugan E. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomedicine & Preventive Nutrition 2013, 3:64-73.
41. Kosińska A., Andlauer W. Modulation of tight junction integrity by food components. Food Research International 2013, 54:951-960.
42. Kovacs-Nolan J., Zhang H., Ibuki M., Nakamori T., Yoshiura K., Turner P.V., et al. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochimica et Biophysica Acta (BBA) - General Subjects 2012, 1820:1753-1763.
43. Krug S.M., Amasheh M., Dittmann I.,I.,C., Fromm M., Amasheh S. Sodium caprate as an enhancer of macromolecule permeation across tricullular tight junctions of intestinal cells. Biomaterials 2013, 34:275-282.
44. Larregieu C.A., Benet L.Z. Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery. Molecular Pharmaceutics 2014, 11:1335-1344.
45. Laukoetter M.G., Nava P., Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World Journal of Gastroenterology: WJG 2008, 14:401-407.
46. Lee J.K., Jeon J.-K., Byun H.-G. Antihypertensive effect of novel angiotensin I converting enzyme inhibitory peptide from chum salmon (Oncorhynchus keta) skin in spontaneously hypertensive rats. Journal of Functional Foods 2014, 7:381-389.
47. Leong K.H., Chung L.Y., Noordin M.I., Onuki Y., Morishita M., Takayama K. Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery. Carbohydrate Polymers 2011, 86:555-565.
48. Lewis A.L., Richard J. Challenges in the delivery of peptide drugs: an industry perspective. Therapeutic Delivery 2015, 6:149-163.
49. Liang H., Zhou B., He L., An Y., Lin L., Li Y., et al. Fabrication of zein/quaternized chitosan nanoparticles for the encapsulation and protection of curcumin. RSC Advances 2015, 5:13891-13900.
50. Li Z., Gu L. Fabrication of self-assembled (-)-Epigallocatechin Gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells. Journal of Agricultural and Food Chemistry 2014, 62:1301-1309.
51. Li Y., Kim J., Park Y., McClements D.J. Modulation of lipid digestibility using structured emulsion-based delivery systems: comparison of in vivo and in vitro measurements. Food & Function 2012, 3:528-536.
52. Lin L., Yee S.W., Kim R.B., Giacomini K.M. SLC transporters as therapeutic targets: emerging opportunities. Nature Reviews Drug Discovery 2015, 14:543-560.
53. Liu J., Willför S., Xu C. A review of bioactive plant polysaccharides: biological activities, functionalization, and biomedical applications. Bioactive Carbohydrates and Dietary Fibre 2015, 5:31-61.
54. Lotito S.B., Zhang W.J., Yang C.S., Crozier A., Frei B. Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties. Free Radical Biology and Medicine 2011, 51:454-463.
55. Lu X., Gao H., Li C., Yang Y.W., Wang Y., Fan Y., et al. Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin. International Journal of Pharmaceutics 2012, 423:195-201.
56. Maher S., Duffy B., Ryan A., Brayden D.J. Formulation strategies to improve oral peptide delivery. Pharmaceutical Patent Analyst 2014, 3:313-336.
57. Maki K.C., Yurko-Mauro K., Dicklin M.R., Schild A.L., Geohas J.G. A new microalgal DHA-and EPA-containing oil lowers triacylglycerols in adults with mild-to-moderate hypertriglyceridemia. Prostaglandins, Leukotrienes and Essential Fatty Acids 2014, 91:141-148.
58. Mannarino M.R., Ministrini S., Pirro M. Nutraceuticals for the treatment of hypercholesterolemia. European Journal of Internal Medicine 2014, 25:592-599.
59. Martin D.A., Bolling B.W. A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases. Food and Function 2015, 6:1773-1786.
60. McCartney F., Gleeson J.P., Brayden D.J. Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers 2016, 4(2). e1176822.
61. McClements D.J. Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals. Therapeutic Delivery 2013, 4:841-857.
62. McClements D.J. Utilizing food effects to overcome challenges in delivery of lipophilic bioactives: structural design of medical and functional foods. Expert Opinion on Drug Delivery 2013, 10:1621-1632.
63. McClements D.J., Decker E.A., Park Y., Weiss J. Structural design principles for delivery of bioactive components in nutraceuticals and functional foods. Critical Reviews in Food Science and Nutrition 2009, 49:577-606.
64. McClements D.J., Li F., Xiao H. The nutraceutical bioavailability classification scheme: classifying nutraceuticals according to factors limiting their oral bioavailability. Annual Review of Food Science and Technology 2015, 6:299-327.
65. McClements D.J., Xiao H. Excipient foods: designing food matrices that improve the oral bioavailability of pharmaceuticals and nutraceuticals. Food & Function 2014, 5:1320-1333.
66. Melmed S., Popovic V., Bidlingmaier M., Mercado M., Lely A.J.v.d., Biermasz N., et al. Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. The Journal of Clinical Endocrinology & Metabolism 2015, 100:1699-1708.
67. Memvanga P.B., Coco R., Préat V. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. Journal of Controlled Release 2013, 172:904-913.
68. Menotti A., Puddu P.E. How the Seven Countries Study contributed to the definition and development of the Mediterranean diet concept: a 50-year journey. Nutrition, Metabolism, and Cardiovascular Diseases 2015, 25:245-252.
69. Morishita M., Morishita I., Takayama K., Machida Y., Nagai T. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. Biological and Pharmaceutical Bulletin 1993, 16:68-72.
70. Müller C., Leithner K., Hauptstein S., Hintzen F., Salvenmoser W., Bernkop-Schnürch A. Preparation and characterization of mucus-penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications. Journal of Nanoparticle Research 2012, 15:1-13.
71. Müller C., Perera G., König V., Bernkop-Schnürch A. Development and in vivo evaluation of papain-functionalized nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2014, 87:125-131.
72. Mun S., Kim Y.-R., McClements D.J. Control of β-carotene bioaccessibility using starch-based filled hydrogels. Food Chemistry 2015, 173:454-461.
73. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 1995, 78:777-783.
74. Nui Y., Ke D., Yang Q., Wang X., Chen Z., An X., et al. Temperature-dependent stability and DPPH scavenging activity of liposomal curcumin at pH 7.0. Food Chemistry 2012, 135:1377-1382.
75. Pandita D., Kumar S., Poonia N., Lather V. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Research International 2014, 62:1165-1174.
76. Pando D., Gutiérrez G., Coca J., Pazos C. Preparation and characterization of niosomes containing resveratrol. Journal of Food Engineering 2013, 117:227-234.
77. Pan M.-H., Lai C.-S., Dushenkov S., Ho C.-T. Modulation of inflammatory genes by natural dietary bioactive compounds. Journal of Agricultural and Food Chemistry 2009, 57:4467-4477.
78. Patel K.R., Scott E., Brown V.A., Gescher A.J., Steward W.P., Brown K. Clinical trails of resveratrol. Annals of the New York Academy of Sciences 2011, 1215:161-169.
79. Penalva R., Esparza I., Larraneta E., Gonzalez-Navarro C.J., Gamazo C., Irache J.M. Zein-based nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shock. Journal of Agricultural and Food Chemistry 2015, 63:5603-5611.
80. Pereira de Sousa I., Cattoz B., Wilcox M.D., Griffiths P.C., Dalgliesh R., Rogers S., et al. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. European Journal of Pharmaceutical Sciences 2015, 97(Pt A):257-264.
81. Petersen S.B., Nielsen L.G., Rahbek U.L., Guldbrandt M., Brayden D.J. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer. European Journal of Pharmaceutical Sciences 2013, 48:726-734.
82. Renukuntla J., Vadlapudi A.D., Patel A., Boddu S.H., Mitra A.K. Approaches for enhancing oral bioavailability of peptides and proteins. International Journal of Pharmaceutics 2013, 447:75-93.
83. Ron N., Zimet P., Bargarum J., Livney Y.D. Beta-lactoglobulin-polysaccharide complexes as nanovehicles for hydrophobic nutraceuticals in non-fat foods and clear beverages. International Dairy Journal 2010, 20:686-693.
84. Ryan S.M., McMorrow J., Umerska A., Patel H.B., Kornerup K.N., Tajber L., et al. An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis. Journal of Controlled Release 2013, 167:120-129.
85. Sarika P.R., Pavithran A., James N.R. Cationized gelatin/gum arabic polyelectrolyte complex: study of electrostatic interactions. Food Hydrocolloids 2015, 49:176-182.
86. Shin G.H., Chung S.K., Kim J.T., Joung H.J., Park H.J. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method. Journal of Agricultural and Food Chemistry 2013, 61:11119-11126.
87. Sigurdsson H.H., Kirch J., Lehr C.-M. Mucus as a barrier to lipophilic drugs. International Journal of Pharmaceutics 2013, 453:56-64.
88. Skulas-Ray A.C. Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. Prostaglandins and Other Lipid Mediators 2015, 116-117:104-111.
89. Stern W., Mehta N., Carl S. Oral delivery of peptides by peptelligenceTM technology. Drug Development and Delivery 2013, 13:38-42.
90. Sung M.-R., Xiao H., Decker E.A., McClements D.J. Fabrication, characterization and properties of filled hydrogel particles formed by the emulsion-template method. Journal of Food Engineering 2015, 155:16-21.
91. Szuts A., Szabó-Révész P. Sucrose esters as natural surfactants in drug delivery systems-a mini-review. International Journal of Pharmaceutics 2012, 433:1-9.
92. Takatsuka S., Kitazawa T., Morita T., Horikiri Y., Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. European Journal of Pharmaceutics and Biopharmaceutics 2006, 62:52-58.
93. Tan C., Xue J., Lou X., Abbas S., Guan Y., Feng B., et al. Liposomes as delivery systems for carotenoids: comparative studies of loading ability, storage stability and in vitro release. Food and Function 2014, 5:1232-1240.
94. Tavano L., Muzzalupa R., Picci N., de Cindo B. Co-encapsulation of antioxidants into niosomal carriers: gastrointestinal release studies for nutraceutical applications. Colloids and Surfaces B: Biointerfaces 2014, 114:82-88.
95. Ting Y., Chiou Y.-S., Pan M.-H., Ho C.-T., Huang Q. In vitro and in vivo anti-cancer activity of tangeretin against colorectal cancer was enhanced by emulsion-based delivery system. Journal of Functional Foods 2015, 15:264-273.
96. Turpeinen A.M., Jarvenpaa S., Kautiainen H., Korpela R., Vapaatalo H. Antihypertensive effects of bioactive tripeptides - a random effects meta-analysis. Annals of Medicine 2013, 45:51-56.
97. Tuvia S., Atsmon J., Teichman S.L., Katz S., Salama P., Pelled D., et al. Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression. The Journal of Clinical Endocrinology & Metabolism 2012, 97:2362-2369.
98. Tuvia S., Pelled D., Marom K., Salama P., Levin-Arama M., Karmeli I., et al. A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms. Pharmaceutical Research 2014, 31:2010-2021.
99. Uluata S., McClements D.J., Decker E.A. How the multiple antioxidant properties of ascorbic acid affect lipid oxidation in oil-in-water emulsions. Journal of Agricultural and Food Chemistry 2015, 63:1819-1824.
100. Vigors S., Sweeney T., O'Shea C.J., Browne J.A., O'Doherty J.V. Improvements in growth performance, bone mineral status and nutrient digestibility in pigs following the dietary inclusion of phytase are accompanied by modifications in intestinal nutrient transporter gene expression. British Journal of Nutrition 2014, 112:688-697.
101. Walker R., Decker E.A., McClements D.J. Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids: opportunities and obstacles in the food industry. Food & Function 2015, 6:42-55.
102. Wallace T., Weaver C., Alexander D., Boushey C., Dawson-Hughes B., Lappe J., et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from NOF. The FASEB Journal 2015, 29.
103. Wang X., Maher S., Brayden D.J. Restoration of rat colonic epithelium after in situ intestinal instillations of the absorption promoter, sodium caprate. Therapeutic Delivery 2010, 1:75-82.
104. Xiao J., Nian S., Huang Q. Assembly of kafirin/carboxymethyl chitosan nanoparticles to enhance the cellular uptake of curcumin. Food Hydrocolloids 2015, 51:166-175.
105. Xia S., Tan C., Zhang Y., Abbas S., Feng B., Zhang Z. Modulating effect of lipid bilayer-carotenoid interactions on the property of liposome encapsulation. Colloids and Surfaces B: Biointerfaces 2015, 128:172-180.
106. Xue J., Zhong Q. Thyme oil nanoemulsions coemulsified by sodium caseinate and lecithin. Journal of Agricultural and Food Chemistry 2014, 62:9900-9907.
107. Xu J.Y., Qin L.Q., Wang P.Y., Li W., Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008, 24:933-940.
108. Yuan S., Hollinger M., Lachowicz-Scroggins M.E., Kerr S.C., Dunican E.M., Daniel B.M., et al. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels. Science Translational Medicine 2015, 7. 276ra227-276ra227.
109. Zhang Z., Gao F., Bu H., Xiao J., Li Y. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine: Nanotechnology, Biology and Medicine 2012, 8:740-747.
110. Zheng J., Li Y., Song M., Fang X., Cao Y., McClements D.J., et al. Improving intracellular uptake of 5-demethyltangeretin by food grade nanoemulsions. Food Research International 2014, 62:98-103.